The Supreme Court Wednesday once again asked pharma company Novartis to scale down the price of its cancer drug Glivec, made from compound imatinib mesylate.
The Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man.
Day in Pics: 1st September
Showbiz World - September 1, 2014
Famous Ganesh Pandals in Mumbai